El-Bab Mohamed F, Shawky Nashaat, Al-Sisi Ali, Akhtar Mohamed
Department of Physiology, Faculty of Medicine, Suez Canal University, Ismailia.
Clin Ophthalmol. 2012;6:269-76. doi: 10.2147/OPTH.S27363. Epub 2012 Feb 17.
Diabetes mellitus is accompanied by chronic and dangerous microvascular changes affecting most body systems, especially the eye, leading to diabetic retinopathy. Diabetic retinopathy without appropriate management is emerging as one of the leading causes of blindness. Therefore, it is necessary to improve the early diagnosis of diabetic retinopathy, reduce the risk of blindness, and identify relevant risk factors.
This descriptive study was designed to estimate the prevalence of retinopathy and its staging in diabetic patients attending the diabetes clinic at King Fahd Hospital in Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia, from 2008 to 2010. Patients completed a questionnaire, underwent a full medical assessment carried out by the treating clinicians, and were examined for evidence of diabetic retinopathy using standard ophthalmic outpatient instruments.
In total, 690 randomly selected diabetic patients of mean age 46.10 ± 11.85 (range 16-88) years were included, comprising 395 men (57.2%) of mean age 46.50 ± 11.31 years and 295 women (42.8%) of mean age 45.55 ± 12.53 years. The mean duration of diabetes mellitus was 11.91 ± 7.92 years in the women and 14.42 ± 8.20 years in the men, and the mean total duration of known diabetes mellitus was 13.35 ± 8.17 years. Glycated hemoglobin was higher in men (8.53% ± 1.81%) than in women (7.73% ± 1.84%), and this difference was statistically significant (P ≤ 0.0001). Of the 690 diabetic patients, 249 (36.1%) had retinopathy. Mild nonproliferative diabetic retinopathy was present in 13.6% of patients, being of moderate grade in 8% and of severe grade in 8.1%. A further 6.4% had proliferative diabetic retinopathy.
Regular screening to detect diabetic retinopathy is strongly recommended because early detection has the best chance of preventing retinal complications.
糖尿病伴有慢性且危险的微血管病变,影响大多数身体系统,尤其是眼睛,可导致糖尿病视网膜病变。未经适当治疗的糖尿病视网膜病变正成为失明的主要原因之一。因此,有必要改善糖尿病视网膜病变的早期诊断,降低失明风险,并确定相关危险因素。
本描述性研究旨在评估2008年至2010年期间在沙特阿拉伯麦地那市法赫德国王医院糖尿病门诊就诊的糖尿病患者中视网膜病变的患病率及其分期。患者填写问卷,接受主治医生进行的全面医学评估,并使用标准眼科门诊仪器检查是否有糖尿病视网膜病变的迹象。
总共纳入了690名随机选择的糖尿病患者,平均年龄为46.10±11.85岁(范围16 - 88岁),其中包括395名男性(57.2%),平均年龄为46.50±11.31岁,以及295名女性(42.8%),平均年龄为45.55±12.53岁。女性糖尿病的平均病程为11.91±7.92年,男性为14.42±8.20年,已知糖尿病的平均总病程为13.35±8.17年。糖化血红蛋白男性(8.53%±1.81%)高于女性(7.73%±1.84%),且这种差异具有统计学意义(P≤0.0001)。在690名糖尿病患者中,249名(36.1%)患有视网膜病变。轻度非增殖性糖尿病视网膜病变在13.6%的患者中存在,中度为8%,重度为8.1%。另有6.4%患有增殖性糖尿病视网膜病变。
强烈建议定期进行筛查以检测糖尿病视网膜病变,因为早期发现最有可能预防视网膜并发症。